These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4205800)

  • 1. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
    Kaye C
    Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic cerebrovascular insufficiency in the elderly. Perspectives on treatment.
    Rosen HJ
    J Med Soc N J; 1972 May; 69(5):445-8. PubMed ID: 4623096
    [No Abstract]   [Full Text] [Related]  

  • 4. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 8. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 9. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 10. [On treatment of acute cerebrovascular accidents].
    Berselli L; Ferracini R
    Clinica; 1965 Sep; 25(1):68-75. PubMed ID: 4954699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 13. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of treatment with SEN DCS-1. Preliminary note on 24 patients].
    Pastor Franco A
    Rev Clin Esp; 1970 Aug; 118(4):359-64. PubMed ID: 4991986
    [No Abstract]   [Full Text] [Related]  

  • 15. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sympatholytic vasodilator in cerebral circulation disorders].
    Lipke PR
    Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of hydergine on cerebrovascular insufficiencies in hypertensive patients].
    Pacheco e Silva A
    Hospital (Rio J); 1970 Jul; 78(1):49-53. PubMed ID: 4991828
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution to the study of memory in a group of senile patients (before and after treatment with a dihydrogenated ergot derivative)].
    Monteverdi T; Manara E
    Rass Neuropsichiatr; 1966; 20(1):41-8. PubMed ID: 4965680
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.